Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March
February 12, 2026
Crinetics Initiates Phase 2/3 Pediatric Trial Evaluating Atumelnant in Congenital Adrenal Hyperplasia (CAH)
January 23, 2026
←
Previous Page
1
2